USD 0.35
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 | 3.81 Million USD | -7.82% |
2023 | 4.13 Million USD | -13.73% |
2022 | 4.79 Million USD | -15.32% |
2021 | 5.65 Million USD | 19.46% |
2020 | 4.73 Million USD | 38.2% |
2019 | 3.42 Million USD | 5.4% |
2018 | 3.25 Million USD | 6.03% |
2017 | 3.06 Million USD | -19.5% |
2016 | 3.81 Million USD | -19.38% |
2015 | 4.72 Million USD | -23.91% |
2014 | 6.21 Million USD | 3.81% |
2013 | 5.98 Million USD | -6.65% |
2012 | 6.4 Million USD | 18.45% |
2011 | 5.41 Million USD | 0.97% |
2010 | 5.35 Million USD | 7.83% |
2009 | 4.97 Million USD | 0.52% |
2008 | 4.94 Million USD | 12.69% |
2007 | 4.38 Million USD | 14.94% |
2006 | 3.81 Million USD | -7.05% |
2005 | 4.1 Million USD | 5.73% |
2004 | 3.88 Million USD | 32.42% |
2003 | 2.93 Million USD | 21.53% |
2002 | 2.41 Million USD | -5.13% |
2001 | 2.54 Million USD | -24.99% |
2000 | 3.39 Million USD | -37.53% |
1999 | 5.42 Million USD | -28.25% |
1998 | 7.56 Million USD | -33.28% |
1997 | 11.34 Million USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 4.68 Million USD | 19.77% |
2024 Q1 | 3.91 Million USD | -5.3% |
2024 FY | 3.81 Million USD | -7.82% |
2024 Q3 | 4.28 Million USD | -8.58% |
2024 Q4 | 3.81 Million USD | -11.1% |
2023 Q3 | 4.09 Million USD | -10.69% |
2023 Q1 | 4.81 Million USD | 0.56% |
2023 FY | 4.13 Million USD | -13.73% |
2023 Q4 | 4.13 Million USD | 0.9% |
2023 Q2 | 4.58 Million USD | -4.81% |
2022 Q1 | 5.65 Million USD | -0.12% |
2022 Q2 | 5.67 Million USD | 0.34% |
2022 Q3 | 5.31 Million USD | -6.21% |
2022 Q4 | 4.79 Million USD | -9.91% |
2022 FY | 4.79 Million USD | -15.32% |
2021 FY | 5.65 Million USD | 19.46% |
2021 Q2 | 5.28 Million USD | 7.05% |
2021 Q1 | 4.93 Million USD | 4.22% |
2021 Q4 | 5.65 Million USD | 10.25% |
2021 Q3 | 5.13 Million USD | -2.88% |
2020 Q4 | 4.73 Million USD | 3.43% |
2020 Q2 | 4.14 Million USD | -4.53% |
2020 Q3 | 4.58 Million USD | 10.41% |
2020 FY | 4.73 Million USD | 38.2% |
2020 Q1 | 4.34 Million USD | 26.76% |
2019 Q4 | 3.42 Million USD | -6.32% |
2019 Q3 | 3.65 Million USD | 10.14% |
2019 Q1 | 3.28 Million USD | 0.86% |
2019 FY | 3.42 Million USD | 5.4% |
2019 Q2 | 3.32 Million USD | 1.28% |
2018 Q1 | 3.12 Million USD | 2.02% |
2018 Q3 | 3.22 Million USD | 3.49% |
2018 Q4 | 3.25 Million USD | 0.71% |
2018 FY | 3.25 Million USD | 6.03% |
2018 Q2 | 3.12 Million USD | -0.29% |
2017 Q2 | 3.39 Million USD | -8.5% |
2017 Q3 | 3.22 Million USD | -4.78% |
2017 FY | 3.06 Million USD | -19.5% |
2017 Q1 | 3.7 Million USD | -2.76% |
2017 Q4 | 3.06 Million USD | -4.99% |
2016 Q4 | 3.81 Million USD | -3.86% |
2016 FY | 3.81 Million USD | -19.38% |
2016 Q1 | 4.36 Million USD | -7.74% |
2016 Q2 | 3.99 Million USD | -8.44% |
2016 Q3 | 3.96 Million USD | -0.73% |
2015 Q4 | 4.72 Million USD | -7.88% |
2015 FY | 4.72 Million USD | -23.91% |
2015 Q2 | 5.37 Million USD | -7.15% |
2015 Q1 | 5.79 Million USD | -6.77% |
2015 Q3 | 5.13 Million USD | -4.58% |
2014 Q1 | 6.26 Million USD | 4.71% |
2014 FY | 6.21 Million USD | 3.81% |
2014 Q4 | 6.21 Million USD | -16.4% |
2014 Q3 | 7.42 Million USD | 24.42% |
2014 Q2 | 5.97 Million USD | -4.69% |
2013 Q4 | 5.98 Million USD | -3.31% |
2013 Q2 | 6.15 Million USD | -0.32% |
2013 Q1 | 6.17 Million USD | -3.59% |
2013 FY | 5.98 Million USD | -6.65% |
2013 Q3 | 6.18 Million USD | 0.47% |
2012 Q1 | 5.74 Million USD | 6.21% |
2012 Q4 | 6.4 Million USD | 7.07% |
2012 FY | 6.4 Million USD | 18.45% |
2012 Q2 | 5.57 Million USD | -2.94% |
2012 Q3 | 5.98 Million USD | 7.31% |
2011 Q4 | 5.41 Million USD | 4.96% |
2011 Q3 | 5.15 Million USD | -0.21% |
2011 FY | 5.41 Million USD | 0.97% |
2011 Q2 | 5.16 Million USD | -5.08% |
2011 Q1 | 5.44 Million USD | 1.56% |
2010 Q1 | 5.05 Million USD | 1.71% |
2010 Q3 | 5.07 Million USD | -1.08% |
2010 FY | 5.35 Million USD | 7.83% |
2010 Q2 | 5.12 Million USD | 1.45% |
2010 Q4 | 5.35 Million USD | 5.64% |
2009 Q2 | 4.72 Million USD | 3.48% |
2009 Q4 | 4.97 Million USD | 4.29% |
2009 Q3 | 4.76 Million USD | 0.93% |
2009 FY | 4.97 Million USD | 0.52% |
2009 Q1 | 4.56 Million USD | -7.71% |
2008 Q1 | 4.24 Million USD | -3.3% |
2008 FY | 4.94 Million USD | 12.69% |
2008 Q3 | 4.62 Million USD | 2.76% |
2008 Q4 | 4.94 Million USD | 6.86% |
2008 Q2 | 4.5 Million USD | 6.13% |
2007 FY | 4.38 Million USD | 14.94% |
2007 Q3 | 4.46 Million USD | 4.0% |
2007 Q1 | 4.17 Million USD | 9.42% |
2007 Q4 | 4.38 Million USD | -1.81% |
2007 Q2 | 4.29 Million USD | 2.87% |
2006 Q4 | 3.81 Million USD | -5.14% |
2006 Q1 | 4.27 Million USD | 4.18% |
2006 Q3 | 4.02 Million USD | 0.15% |
2006 Q2 | 4.01 Million USD | -6.08% |
2006 FY | 3.81 Million USD | -7.05% |
2005 FY | 4.1 Million USD | 5.73% |
2005 Q3 | 3.98 Million USD | -3.92% |
2005 Q1 | 3.97 Million USD | 2.46% |
2005 Q4 | 4.1 Million USD | 3.06% |
2005 Q2 | 4.14 Million USD | 4.22% |
2004 Q2 | 3.92 Million USD | 35.62% |
2004 FY | 3.88 Million USD | 32.42% |
2004 Q3 | 3.98 Million USD | 1.65% |
2004 Q4 | 3.88 Million USD | -2.57% |
2004 Q1 | 2.89 Million USD | -1.42% |
2003 Q2 | 2.63 Million USD | 14.17% |
2003 FY | 2.93 Million USD | 21.53% |
2003 Q4 | 2.93 Million USD | 0.03% |
2003 Q3 | 2.93 Million USD | 11.24% |
2003 Q1 | 2.3 Million USD | -4.33% |
2002 Q1 | 2.56 Million USD | 0.65% |
2002 Q2 | 2.78 Million USD | 8.72% |
2002 FY | 2.41 Million USD | -5.13% |
2002 Q4 | 2.41 Million USD | -2.57% |
2002 Q3 | 2.47 Million USD | -11.02% |
2001 Q3 | 2.61 Million USD | -6.29% |
2001 FY | 2.54 Million USD | -24.99% |
2001 Q2 | 2.79 Million USD | -9.98% |
2001 Q4 | 2.54 Million USD | -2.74% |
2001 Q1 | 3.1 Million USD | -8.58% |
2000 Q4 | 3.39 Million USD | -16.37% |
2000 Q3 | 4.05 Million USD | 0.0% |
2000 FY | 3.39 Million USD | -37.53% |
1999 FY | 5.42 Million USD | -28.25% |
1998 FY | 7.56 Million USD | -33.28% |
1997 FY | 11.34 Million USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
American Medical Technologies Inc. | 1.83 Million USD | -107.323% |
Ansell Limited | 3.23 Billion USD | 99.882% |
Ansell Limited | 3.24 Billion USD | 99.882% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 488.98 Million USD | 99.221% |
BioLife Sciences Inc. | - USD | -Infinity% |
CB Scientific, Inc. | 300.36 Thousand USD | -1168.708% |
Psykey, Inc. | 1.72 Million USD | -120.609% |
ConvaTec Group Plc | 3.7 Billion USD | 99.897% |
ConvaTec Group Plc | 3.71 Billion USD | 99.897% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | - USD | -Infinity% |
Innovative MedTech Inc. | 651.88 Thousand USD | -484.572% |
LifePoint, Inc. | 8.8 Million USD | 56.741% |
Medite Cancer Diagnostics, Inc. | 15.95 Million USD | 76.117% |
Paradigm Medical Industries, Inc. | 895 Thousand USD | -325.778% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | 5.48 Million USD | 30.576% |
Reflect Scientific, Inc. | 2.66 Million USD | -42.782% |
SmileDirectClub, Inc. | 597.06 Million USD | 99.362% |
Sector 10, Inc. | 1000.00 USD | -380971.6% |
Shandong Weigao Group Medical Polymer Company Limited | 4.74 Billion USD | 99.92% |
SheerVision, Inc. | 837.56 Thousand USD | -354.976% |
United Health Products, Inc. | 284.64 Thousand USD | -1238.77% |
Vasamed, Inc. | 1.6 Million USD | -138.134% |
Wearable Health Solutions, Inc. | 223.17 Thousand USD | -1607.517% |
Yubo International Biotech Limited | 2.34 Million USD | -62.258% |